Cite
HARVARD Citation
Mengel, E. et al. (2021). Efficacy and safety of arimoclomol in Niemann‐Pick disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment. Journal of inherited metabolic disease. 44 (6), pp. 1463-1480. [Online].